Donor leukocyte infusions (DLI) to treat leukemia relapse after allogeneic bone marrow transplantation (aloBMT).

被引：0
|
作者：
Reynoso, EE [1 ]
Guevara, AG [1 ]
Miranda, E [1 ]
Salinas, V [1 ]
Acosta, A [1 ]
Sobrevilla, PJ [1 ]
机构：
[1] INST NACL CANC,MEXICO CITY,DF,MEXICO
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3835 / 3835
页数：1
相关论文
共 50 条
  • [21] LEUKEMIA RELAPSE IN DONOR CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEWBURGER, PE
    LATT, SA
    PESANDO, JM
    GUSTASHAW, K
    POWERS, M
    CHAGANTI, RSK
    OREILLY, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (12): : 712 - 714
  • [22] Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
    Collins, RH
    Shpilberg, O
    Drobyski, WR
    Porter, DL
    Giralt, S
    Champlin, R
    Goodman, SA
    Wolff, SN
    Hu, W
    Verfaillie, C
    List, A
    Dalton, W
    Ognoskie, N
    Chetrit, A
    Antin, JH
    Nemunaitis, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 433 - 444
  • [23] Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation
    Lokhorst, HM
    Schattenberg, A
    Cornelissen, JJ
    Thomas, LLM
    Verdonck, LF
    BLOOD, 1997, 90 (10) : 4206 - 4211
  • [24] Prevention of relapse after lymphocyte depleted allogeneic bone marrow transplantation by preemptive donor leukocyte infusions in patients with high risk of relapse.
    Schaap, N
    Schattenberg, A
    Bär, B
    Preijers, F
    de Witte, T
    BLOOD, 1998, 92 (10) : 347B - 347B
  • [25] Donor leukocyte infusions for the treatment of leukemia relapse after allogeneic hematopoietic progenitor cell transplantation.
    Gurman, G
    Arslan, O
    Koc, H
    Dilek, I
    Ustun, C
    Ozcan, M
    Akan, H
    Ilhan, O
    Sunguroglu, A
    Konuk, N
    Uysal, A
    Idilman, R
    Beksac, M
    BLOOD, 1997, 90 (10) : 4452 - 4452
  • [26] Donor leukocyte infusion (DLI) for leukemic relapse after allogeneic marrow transplantation: Persistence or reestablishment of donor hematopoiesis prevents marrow aplasia and improves CR rates after DLI.
    Keil, F
    Haas, OA
    Fritsch, G
    Kalhs, P
    Lechner, K
    Mannhalter, C
    Reiter, E
    Worel, N
    Rabitsch, W
    Niederwieser, D
    Greinix, HT
    BONE MARROW TRANSPLANTATION, 1999, 23 : S45 - S45
  • [27] Donor leukocyte infusion (DLI) for leukemic relapse after allogeneic marrow transplantation: Persistence or reestablishment of donor hematopoiesis prevents marrow aplasia and improves CR rates after DLI.
    Keil, F
    Haas, OA
    Fritsch, G
    Kalhs, P
    Lechner, K
    Mannhalter, C
    Reiter, E
    Worel, N
    Rabitsch, W
    Niederwieser, D
    Greinix, HT
    BLOOD, 1998, 92 (10) : 343B - 343B
  • [28] Long term follow-up of 55 patients who achieved complete remission (CR) after donor leukocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT).
    Porter, DL
    Collins, R
    Drobyski, W
    Connors, JM
    VanHoef, M
    Antin, J
    BLOOD, 1997, 90 (10) : 2444 - 2444
  • [29] Use of donor lymphocyte infusions (DLI) for the treatment of relapse after allogeneic bone marrow transplantation (ABMT): Effective GVT in chronic myeloid leukemia (CML) with no clinical GVHD.
    Hahn, TE
    Alam, AR
    Miller, A
    Meteer, J
    Dascomb, S
    Baer, MR
    Bambach, B
    Bernstein, S
    Bernstein, Z
    Chanan-Khan, A
    Czuczman, M
    Slack, J
    Wetzler, M
    Becker, J
    Stewart, C
    McCarthy, PL
    BLOOD, 2001, 98 (11) : 366B - 366B
  • [30] Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    Depil, S
    Deconinck, E
    Milpied, N
    Sutton, L
    Witz, F
    Jouet, JP
    Damaj, G
    Yakoub-Agha, I
    BONE MARROW TRANSPLANTATION, 2004, 33 (05) : 531 - 534
12345